Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-05-08

Clinical Trial Update: L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether L-Arginine with antioxidant vitamins can reduce preeclampsia during pregnancy; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antioxidant vitamins
  • L-Arginine (L-Arginine)

Snippet

Sponsor: Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes | Conditions: Pre-Eclampsia | Phase 2 | Status: TERMINATED